نتایج جستجو برای: acute generalized exanthematous pustulosis agep

تعداد نتایج: 658116  

2012
Sophie Bouvresse Laurence Valeyrie-Allanore Nicolas Ortonne Marie Pauline Konstantinou Sylvia H Kardaun Martine Bagot Pierre Wolkenstein Jean-Claude Roujeau

BACKGROUND Severe cutaneous adverse reactions to drugs (SCARs) include acute generalized exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms (DRESS) and epidermal necrolysis (Stevens-Johnson syndrome-toxic epidermal necrolysis [SJS-TEN]). Because of the varied initial presentation of such adverse drug reactions, diagnosis may be difficult and suggests overlap ...

Journal: :Annals of dermatology 2011
Hyun-Je Kim Kyu-Dong Jung Kyung-Tae Lee Ji-Yeon Byun Dong-Youn Lee Joo-Heung Lee Jun-Mo Yang Eil-Soo Lee

Acute generalized exanthematous pustulosis is clinically characterized by fever, pruritus and an acute pustular eruption. It can be described as having an abrupt onset and then spontaneous resolution occurs shortly after the start of symptoms, and there is usually only a single episode. Most cases have been triggered by the ingestion of drugs. Diltiazem hydrochloride is a calcium channel blocke...

2016
Nobuko Tabata Hideka Yoshizawa

Generalized pustular lesions characterized by acute onset with fever occur in pustulosis acuta generalisata, acute generalized exanthematous pustulosis, and generalized pustular psoriasis. In the present report, we describe a pediatric case of generalized pustular eruption that was not completely consistent with clinical features. Our patient had no evidence of a post-streptococcal infection. W...

Journal: :Journal of Cutaneous Immunology and Allergy 2018

2016
Laurence Feldmeyer Kristine Heidemeyer Nikhil Yawalkar

Acute generalized exanthematous pustulosis (AGEP) is a severe, usually drug-related reaction, characterized by an acute onset of mainly small non-follicular pustules on an erythematous base and spontaneous resolution usually within two weeks. Systemic involvement occurs in about 20% of cases. The course is mostly benign, and only in rare cases complications lead to life-threatening situations. ...

Journal: :Jurnal respirologi Indonesia 2022

Background: Adverse event studies of favipiravir use in treating COVID-19 have been ongoing since it was established as a treatment option. A better understanding the side effects from recent is important developing and assessing recognition effective treatments for COVID-19. Method: This systematic review based on case reports monotherapy Access to included gained via PubMed, SCOPUS, Science D...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید